University Health Network, Toronto
Clinical trials sponsored by University Health Network, Toronto, explained in plain language.
-
Brain-Monitored blood pressure may cut delirium in elderly heart patients
Disease control Not yet recruitingAbout one in four older adults experiences confusion (delirium) after cardiac surgery, which can lead to longer hospital stays and higher risks. This pilot study tests whether using a brain-monitoring device to personalize blood pressure during surgery can help prevent delirium. …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo aims to tackle deadly pancreatic cancer
Disease control Not yet recruitingThis study tests a new drug called samuraciclib added to standard chemotherapy for people with a specific type of advanced pancreatic cancer (basal-like). The goal is to find the safest dose and see if the combination helps shrink tumors or slow the cancer. About 67 adults with n…
Phase: PHASE1, PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a cheap breast cancer drug fix hormone recovery in prostate cancer patients?
Disease control Not yet recruitingThis study tests whether tamoxifen, a drug commonly used for breast cancer, can speed up testosterone recovery in men with prostate cancer who have completed hormone therapy (ADT). Many men experience low testosterone for months or years after stopping ADT, causing fatigue, depre…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Zapping resistant spots: radiation may buy more time for lung cancer patients on targeted drugs
Disease control Not yet recruitingThis study tests whether precisely targeted radiation (SBRT) can stop or slow the growth of a few resistant spots in metastatic lung cancer patients who are already on targeted therapy (TKI). About 60 adults with EGFR or ALK mutations will receive radiation to those spots, and do…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for CML patients: asciminib combo trial launches
Disease control Not yet recruitingThis phase 2 trial tests asciminib, a newer targeted drug, alone or with dasatinib, in 45 adults with chronic myeloid leukemia (CML) whose first treatment stopped working. The goal is to see if this approach can reduce cancer cells to very low levels within 24 weeks. Patients wit…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Smarter radiation aims to cut side effects in prostate cancer relapse
Disease control Not yet recruitingThis study tests a personalized radiation approach for men whose prostate cancer has returned after surgery. Using PSMA PET scans, doctors will give higher radiation doses to active cancer spots and lower doses to healthy areas, all in just 5 treatments over two weeks. The goal i…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Washing kidneys to stop hidden virus: new trial aims to make transplants safer
Disease control Not yet recruitingThis early-stage trial tests whether treating a donor kidney with a drug called SYN002 before transplant can safely reduce the risk of passing cytomegalovirus (CMV) to the recipient. About 12 adults waiting for a kidney transplant will receive a treated organ. The main goal is to…
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug targets Low-Oxygen tumors in prostate cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding evofosfamide to standard hormone therapy can help men with castration-resistant prostate cancer that has spread. The drug targets low-oxygen areas in tumors. 35 participants will receive the drug combination and be monitored for PSA respons…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug combo takes on rare sarcomas
Disease control Not yet recruitingThis early-phase trial tests a new drug called BOLD-100 combined with standard chemotherapy (doxorubicin) in 32 people with advanced soft tissue sarcomas that cannot be removed by surgery or have spread. The goal is to find the safest dose and see if the combination can shrink tu…
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New device aims to reduce heart transplant complications
Disease control Not yet recruitingThis study tests a new temperature control system (Xo Port) for preserving donor hearts during transplant, compared to the standard ice method. The goal is to see if it reduces severe complications like primary graft dysfunction. About 50 adult heart transplant recipients will ta…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Does this pain device really work? a blinded trial aims to find out
Symptom relief Not yet recruitingThis study tests whether a newer form of spinal cord stimulation (paresthesia-free SCS) actually reduces chronic pain or if its benefits are just a placebo effect. Ninety adults with severe neuropathic pain will receive both active and placebo stimulation for six weeks each, with…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can a volunteer buddy help lung cancer patients feel better?
Symptom relief Not yet recruitingThis study is testing a program called Care and Connect, where trained volunteers provide support and information to people with lung cancer. The goal is to see if this program helps reduce distress and makes it easier for patients to get the care they need. About 50 adults with …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New therapy aims to ease trauma in ovarian cancer patients
Symptom relief Not yet recruitingThis phase III trial tests a therapy called CALM-TF for women with advanced ovarian cancer who experience traumatic stress. 300 participants will either receive 3-6 sessions of this trauma-focused therapy or standard care. Researchers will measure stress, depression, and quality …
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Shoulder surgery patients asked: is one shot enough?
Knowledge-focused Not yet recruitingThis study surveys 140 adults who had keyhole shoulder surgery with a single-injection nerve block plus general anesthesia. Researchers want to learn about patients' pain and recovery experiences to identify who might prefer a continuous nerve catheter instead. The goal is to imp…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
AI learns to see What's in your stomach: a new tool for anesthesiologists?
Knowledge-focused Not yet recruitingThis study aims to train an artificial intelligence (AI) program to help anesthesiologists interpret stomach ultrasound images. Researchers will take ultrasound pictures of the stomachs of 30 healthy volunteers when they are fasting, after drinking water, and after eating solid f…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Women-Only heart classes aim to boost recovery and knowledge
Knowledge-focused Not yet recruitingThis pilot study will test whether a women-focused education program, called Cardiac College for Women, helps women with heart disease learn more about their condition and feel better. About 50 women in cardiac rehab across Canada will either get the program plus usual care or us…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Apple watch vs. heart failure: can a smartwatch save lives?
Knowledge-focused Not yet recruitingThis study will see if an Apple Watch can help predict when heart failure gets worse. Researchers will compare data from the watch with standard tests in 360 adults with heart failure. The goal is to find a simpler way to monitor patients and catch problems early.
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC